Tissue Factor-Deficiency and Protease Activated Receptor-1-Deficiency Reduce Inflammation Elicited by Diet-Induced Steatohepatitis in Mice

Clark, 2002, Nonalcoholic fatty liver disease, Gastroenterology, 122, 1649, 10.1053/gast.2002.33573 Larter, 2008, Animal models of NASH: getting both pathology and metabolic context right, J Gastroenterol Hepatol, 23, 1635, 10.1111/j.1440-1746.2008.05543.x Farrell, 2006, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology, 43, S99, 10.1002/hep.20973 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Friedman, 2008, Mechanisms of hepatic fibrogenesis, Gastroenterology, 134, 1655, 10.1053/j.gastro.2008.03.003 Koppe, 2004, Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet, J Hepatol, 41, 592, 10.1016/j.jhep.2004.06.030 Sahai, 2004, Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model, Am J Physiol Gastrointest Liver Physiol, 287, G264, 10.1152/ajpgi.00002.2004 Yamaguchi, 2007, Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, 45, 1366, 10.1002/hep.21655 Dela Pena, 2005, NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis, Gastroenterology, 129, 1663, 10.1053/j.gastro.2005.09.004 Yu, 2006, COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator, Hepatology, 43, 826, 10.1002/hep.21108 Ip, 2004, Administration of the potent PPARalpha agonist, Wy-14643, reverses nutritional fibrosis and steatohepatitis in mice, Hepatology, 39, 1286, 10.1002/hep.20170 Nagasawa, 2006, Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet, Eur J Pharmacol, 536, 182, 10.1016/j.ejphar.2006.02.028 Schattenberg, 2006, JNK1 but not JNK2 promotes the development of steatohepatitis in mice, Hepatology, 43, 163, 10.1002/hep.20999 Northup, 2008, Hypercoagulation and thrombophilia in liver disease, J Thromb Haemost, 6, 2, 10.1111/j.1538-7836.2007.02772.x Alessi, 2008, Metabolic syndrome, haemostasis, and thrombosis, Thromb Haemost, 99, 995, 10.1160/TH07-11-0682 Cigolini, 1996, Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men–role of the metabolic syndrome, Thromb Haemost, 76, 69, 10.1055/s-0038-1650524 Kotronen, 2008, Fatty liver: a novel component of the metabolic syndrome, Arterioscler Thromb Vasc Biol, 28, 27, 10.1161/ATVBAHA.107.147538 Mackman, 2007, Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis, Arterioscler Thromb Vasc Biol, 27, 1687, 10.1161/ATVBAHA.107.141911 Luyendyk, 2009, Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice, Am J Physiol Gastrointest Liver Physiol, 296, G840, 10.1152/ajpgi.90639.2008 Mackman, 1993, Murine tissue factor gene expression in vivo: Tissue and cell specificity and regulation by lipopolysaccharide, Am J Pathol, 143, 76 Abiru, 2006, Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis, Liver Int, 26, 39, 10.1111/j.1478-3231.2005.01191.x Farhadi, 2008, Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis, Liver Int, 28, 1026, 10.1111/j.1478-3231.2008.01723.x Haukeland, 2006, Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2, J Hepatol, 44, 1167, 10.1016/j.jhep.2006.02.011 Kudo, 2009, Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model, J Hepatol, 51, 168, 10.1016/j.jhep.2009.02.032 Coughlin, 1999, How the protease thrombin talks to cells, Proc Natl Acad Sci USA, 96, 11023, 10.1073/pnas.96.20.11023 Copple, 2003, Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide-induced hepatocellular injury in perfused livers, J Pharmacol Exp Ther, 305, 417, 10.1124/jpet.102.046391 Cunningham, 2000, Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis, J Exp Med, 191, 455, 10.1084/jem.191.3.455 Olman, 1995, Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse, J Clin Invest, 96, 1621, 10.1172/JCI118201 Sevastos, 2007, Tissue factor deficiency and PAR-1 deficiency are protective against renal ischaemia reperfusion injury, Blood, 109, 577, 10.1182/blood-2006-03-008870 Parry, 1998, Low levels of tissue factor are compatible with development and hemostasis in mice, J Clin Invest, 101, 560, 10.1172/JCI814 Connolly, 1997, Mice lacking the thrombin receptor. PAR1, have normal skin wound healing, Am J Pathol, 151, 1199 Ganey, 2007, Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice, Hepatology, 46, 1177, 10.1002/hep.21779 Tanaka, 2008, NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet, J Pharmacol Exp Ther, 325, 655, 10.1124/jpet.107.135822 Weiler-Guettler, 1998, A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state, J Clin Invest, 101, 1983, 10.1172/JCI2006 Gaca, 2002, Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors, J Hepatol, 36, 362, 10.1016/S0168-8278(01)00285-9 Stephenne, 2007, Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation, Liver Transpl, 13, 599, 10.1002/lt.21128 Fiorucci, 2004, PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation, Hepatology, 39, 365, 10.1002/hep.20054 Mochida, 1999, Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats, Hepatology, 29, 1532, 10.1002/hep.510290533 Mackman, 1996, Regulation of tissue factor gene expression in human monocytic and endothelial cells, Haemostasis, 26, 17 Schwertz, 2006, Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets, J Exp Med, 203, 2433, 10.1084/jem.20061302 Edens, 2009, Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers, Obes Rev, 10, 412, 10.1111/j.1467-789X.2009.00594.x Greco, 2008, Gene expression in human NAFLD, Am J Physiol Gastrointest Liver Physiol, 294, G1281, 10.1152/ajpgi.00074.2008 Yao, 1988, The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes, J Biol Chem, 263, 2998, 10.1016/S0021-9258(18)69166-5 Esmon, 2005, The interactions between inflammation and coagulation, Br J Haematol, 131, 417, 10.1111/j.1365-2141.2005.05753.x Kudo, 2009, Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model, J Hepatol, 51, 168, 10.1016/j.jhep.2009.02.032 Koca, 2008, The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet, Inflammation, 31, 91, 10.1007/s10753-007-9053-z Tomita, 2006, Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice, Gut, 55, 415, 10.1136/gut.2005.071118 Yu, 2008, Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice, Biochem Biophys Res Commun, 372, 571, 10.1016/j.bbrc.2008.05.069 Nocito, 2007, Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis, Gastroenterology, 133, 608, 10.1053/j.gastro.2007.05.019 Ikura, 2006, Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression, Hepatology, 43, 506, 10.1002/hep.21070 Dambach, 2002, Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse, Hepatology, 35, 1093, 10.1053/jhep.2002.33162 Hildebrand, 2006, Kupffer cells and their mediators: the culprits in producing distant organ damage after trauma-hemorrhage, Am J Pathol, 169, 784, 10.2353/ajpath.2006.060010 Hokeness, 2005, Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver, J Immunol, 174, 1549, 10.4049/jimmunol.174.3.1549 Kuziel, 1997, Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2 (gene targeting/monocyte chemoattractant protein 1/trafficking/peritonitis/granuloma), Proc Natl Acad Sci USA, 94, 12053, 10.1073/pnas.94.22.12053 Marra, 1998, Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration, Am J Pathol, 152, 423 Rizki, 2006, Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1, J Lipid Res, 47, 2280, 10.1194/jlr.M600198-JLR200 DeLeve, 2008, Prevention of hepatic fibrosis in a murine model of metabolic syndrome with non-alcoholic steatohepatitis, Am J Pathol, 173, 993, 10.2353/ajpath.2008.070720 Xu, 2009, Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats, Dig Dis Sci Samad, 2001, Regulation of tissue factor gene expression in obesity, Blood, 98, 3353, 10.1182/blood.V98.12.3353